combination therapies outperforming semaglutide Trial suggests GLP-1 combo therapy cuts fat while preserving muscle in obesity Semaglutide Dose Escalation and Weight

Interventions that support mitochondrial efficiency, stabilize nutrient sensing, and limit the accumulation of senescent cells may contribute to preserving physiological resilience, even if they do not directly alter the primary drivers of aging

Improved Metabolic Markers: Beyond weight loss, these treatments may positively influence blood sugar, cholesterol, and blood pressure levels

Regular intake of 2 g per day for at least two weeks can produce a small but significant decrease in BMI (~1.5%)

There is limited information about the long-term use of oral glutathione for cosmetic purposes

Early vascular evaluation can help detect blood flow problems before they become serious.

Yes, it may increase during dose escalation, which is why GLP-1 medicines are introduced gradually